8 unknown. 8 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 8 |
| Phase 1 | 1 | Unknown 1 |
Follow Histiocytoma: new trials by email Literature Review of Histiocytoma trials Research Report on Histiocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma Envafolimab, Ipilimumab - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 2 | Unknown | Tracon Pharmaceuticals Inc. | 207 | 2020-12-09 | 2024-05-17 |
| Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma Anlotinib, Toripalimab, Blood Draw - Soft Tissue Sarcomas, Undifferentiated Pleomorphic Sarcoma | Phase 2 | Unknown | Di Wu | 25 | 2019-07-19 | 2019-07-10 |
| Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas Hypofractionated radiotherapy, Hyperthermia - Sarcoma, Alveolar Soft Part Sarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 30 | 2018-06-01 | 2021-02-01 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 46 | 2017-02-11 | 2021-01-22 |
| Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma Autologous dendritic cell vaccine - Sarcoma, Neoplasms, Connective and Soft Tissue | Phase 1 / Phase 2 | Unknown | N.N. Petrov National Medical Research Center of Oncology | 48 | 2013-06-01 | 2019-11-20 |
| External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases indinavir sulfate, ritonavir, radiation therapy - Cancer | Phase 2 | Unknown | Oncology Institute of Southern Switzerland | 60 | 2007-09-01 | 2013-08-12 |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma brostallicin, doxorubicin hydrochloride - Ovarian Cancer, Sarcoma | Phase 2 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 118 | 2006-10-01 | 2014-08-08 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma temozolomide - Endometrial Cancer, Ovarian Cancer | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 25 | 1998-09-01 | 2014-01-06 |
Histiocytoma, Malignant Fibrous (8) · Sarcoma (7) · Fibrosarcoma (5) · Leiomyosarcoma (5) · Liposarcoma (5) · Neurofibrosarcoma (5) · Sarcoma, Synovial (5) · Sarcoma, Alveolar Soft Part (4) · Rhabdomyosarcoma (3) · Dermatofibrosarcoma (2) · Endometrial Neoplasms (2) · Hemangiosarcoma (2) · Liposarcoma, Myxoid (2) · Malignant mesenchymal tumor (2) · Myosarcoma (2)
Neoplasms by Histologic Type (8) · Neoplasms, Connective Tissue (8) · Neoplasms, Fibrous Tissue (8) · Neoplasms (7) · Neoplasms, Connective and Soft Tissue (7) · Neoplasms, Nerve Tissue (6) · Nervous System Diseases (6) · Nervous System Neoplasms (6) · Neoplasms, Adipose Tissue (5) · Neoplasms, Muscle Tissue (5) · Nerve Sheath Neoplasms (5) · Neurofibroma (5) · Neuromuscular Diseases (5) · Peripheral Nervous System Diseases (5)
Radiation Dose Hypofractionation (2) · Biopsy, Needle (1) · Blood Specimen Collection (1) · Diathermy (1) · Doxorubicin (1) · Indinavir (1) · Ipilimumab (1) · Phlebotomy (1) · Radiotherapy (1) · Ritonavir (1) · Temozolomide (1) · anlotinib (1) · brostallicin (1) · envafolimab (1) · lentiviral minigene vaccine of COVID-19 coronavirus (1)
Maria Sklodowska-Curie National Research Institute of Oncology (2) · Di Wu (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Herbert Irving Comprehensive Cancer Center (1) · N.N. Petrov National Medical Research Center of Oncology (1) · Oncology Institute of Southern Switzerland (1) · Tracon Pharmaceuticals Inc. (1)
Poland (2) · United States (2) · China (1) · Netherlands (1) · Russia (1) · Switzerland (1) · United Kingdom (1)
Charles Theuer, MD, PhD (1) · Hans Gelderblom, MD, PhD (1) · Ilja Ciernik, MD (1) · Robert N. Taub, MD, PhD (1) · Yuriy Komarov, PhD (1)